NCT00001823

Evaluation for NCI Surgery Branch Clinical Research Protocols

← Centro de ensayos clínicos

Campos del registro

Estado general
RECRUITING
Condiciones
Synovial Cell Cancer, Melanoma, Colorectal Cancer, Lung Cancer, Bladder Cancer
Tipo de estudio
OBSERVATIONAL
Patrocinador principal
National Cancer Institute (NCI) (NIH)

En caché: 2026-10-09 02:00:52

Ver en ClinicalTrials.gov

Resumen breve

Background:

The National Cancer Institute Surgery Branch (NCI-SB) has developed experimental therapies that involve taking white blood cells from patients' tumor or from their blood, growing them in the laboratory in large numbers, and then giving the cells back to the patient.

Objective:

This study will allow patients to under screening and evaluation for participation in NC-SB Protocols.

Eligibility:

Patients 18 years or older must meet the minimum eligibility criteria for an NCI-SB treatment protocol.

Design

Patients will undergo testing and evaluations as required by the appropriate NCI-SB treatment protocol.

Contacto

¿Necesita un informe o redacción médica basada en este ensayo?